Arvinas

ARVNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$572.129 M

$8.75 +0.81%

Close of 7 Aug 2026

Revenue

$262.6M

#2201 by revenue

Earnings

-$81.0M

Loss-making

Shares outstanding

65,386,191

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#198VerastemVSTM$592.3M
#199CorMedixCRMD$583.7M
#200ArvinasARVN$572.1M
#201Contineum TherapeuticsCTNM$565.8M
#202Sagimet BiosciencesSGMT$559.5M

Where these numbers come from

Share counts and financials for Arvinas are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.